IP Library Granted Patent US 7,241,813
Granted Patent B2
US 7,241,813 · App. 10/326,339 · Granted Jul 10, 2007

End-capped polymers and compositions containing such compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,813
App. No.
10/326,339
Granted
Jul 10, 2007
Kind
B2
Abstract

End-capped polymers, methods for making those end-capped polymers and compositions containing those end-capped polymers are disclosed. One of the disclosed end-capped copolymers has the formula: and may be combined with demineralized bone particles to form a tissue repair composition.

Claims (16)

1. A polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer wherein both terminal hydroxyl groups in the triblock copolymer have been replaced with terminal methoxy groups and wherein the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer

is derived from a dilithium salt of a dihydroxy starting material, and wherein both of the terminal hydroxyl groups have been replaced with terminal methoxy groups as a result of chemical modification.

2. The compound of claim 1 , wherein the degree of polymerization of both polyoxyethylene blocks is about 101 and the degree of polymerization of the polyoxypropylene block is about 56.

3. A method of making polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer wherein both terminal hydroxyl groups in the triblock copolymer have been replaced with terminal methoxy groups and wherein the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer has no hydroxyl groups comprising:

(a) providing a polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer with two terminal hydroxyl groups

(b) contacting the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer defined in step (a) with butyllithium or lithium aluminum hydride to form a dilithium salt and

(c) contacting the product of step (b) with methyl iodide, resulting in complete conversion of all hydroxyl groups in the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer of step (a) into methyl ethers.

4. The method of claim 3 , wherein the degree of polymerization of both polyoxyethylene blocks is about 101 and the degree of polymerization of the polyoxypropylene block is about 56.

5. A composition comprising:

(i) demineralized bone particles, and

(ii) a polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer wherein both terminal hydroxyl groups in the triblock copolymer have been replaced with terminal methoxy groups and wherein the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer wherein the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer

derived from a dilithium salt of a dihydroxy starting material and wherein all of the dihydroxy starting material is completely etherified as a result of chemical modification.

6. The composition according to claim 5 , wherein the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer defined in part (ii) is dispersed in water.

7. The composition according to claim 6 , wherein the dispersion of the polyoxyethylene-polyoxypropylene-polyoxyethylene triblock copolymer defined in part (ii) in water exhibits reverse phase behavior.

8. The composition according to claim 5 , wherein the composition is a tissue repair composition.

9. The composition according to claim 5 , wherein the composition further comprises collagen, gelatin, BMIPs, bone mineral, hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate, calcium sulfate, biological glasses, a natural polymer or a synthetic polymers.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Nov 12, 2024
From: BLUE TORCH FINANCE LLC
To: ISOTIS ORTHOBIOLOGICS, INC.; ORTHOFIX US, LLC; SEASPINE, INC.; SEASPINE ORTHOPEDICS CORPORATION; SPINAL KINETICS LLC; THEKEN SPINE, LLC
Reel/Frame 069358/0110 →
RELEASE OF SECURITY INTEREST Recorded Nov 7, 2024
From: JPMORGAN CHASE BANK, N.A.
To: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
Reel/Frame 069323/0561 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ISOTIS ORTHOBIOLOGICS, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 066258/0555 →
SECURITY INTEREST Recorded Feb 21, 2023
From: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE ASSISTANT
Reel/Frame 062819/0650 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2023
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
Reel/Frame 062336/0593 →
SECOND AMENDMENT TO PATENT SECURITY AGREEMENT Recorded Jul 18, 2022
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 060715/0395 →
SECURITY INTEREST Recorded Dec 28, 2015
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037393/0895 →
CHANGE OF NAME Recorded Feb 10, 2004
From: GENSCI ORTHOBIOLOGICS, INC.
To: ISOTIS ORTHOBIOLOGICS, INC.
Reel/Frame 014321/0216 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2003
From: KAY, JOHN F.; EISCH, JOHN J.
To: GENSCI ORTHOBIOLOGICS, INC.
Reel/Frame 014038/0518 →